Who is sponsoring NCT04479020?

NCT04479020 is sponsored by Acandis GmbH.

What condition does NCT04479020 study?

NCT04479020 studies Acute Stroke.

What drugs are being tested in NCT04479020?

Interventions: Mechanical Thrombectomy.

What is the status of NCT04479020?

NCT04479020 is currently COMPLETED.

Last reviewed 2024-12-06 · How we verify

REcanalization of Distal Cerebral Vessels in Acute Stroke Using ApeRio®

NCT04479020 COMPLETED

The purpose of the REVISAR PMCF is to collect data in clinical practice of the APERIO® and APERIO® Hybrid(17) Thrombectomy Device, which are intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke. Recanalization status will be assessed at the end of the procedure using the modified TICI (Thrombolysis in cerebral infarction) score.

Details

Lead sponsor	Acandis GmbH
Status	COMPLETED
Enrolment	134
Start date	Wed Jul 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed May 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Acute Stroke

Interventions

Mechanical Thrombectomy

Countries

Germany